Join Fenwick for an insightful webinar discussing the USPTO’s recent guidance on the patentability of AI-assisted inventions and what it means for the life sciences industry.
Our Life Sciences and Intellectual Property lawyers will explore what the guidance means for the use of AI in the composition of new drug compounds, biomarker discovery, and diagnostics, including:
This webinar is recorded and is eligible for CLE credit.